FDA Issues 510(k) Clearance to Applied Tissue Technologies’ Platform Wound Dressing (PWD®), A New Negative Pressure Wound Therapy System Without Foam or Gauze
Applied Tissue Technologies (ATT), an advanced wound care company, announced US FDA 510(k) clearance of its Negative Pressure Wound Therapy product, the Platform Wound Dressing (PWD®). Classified
Wound therapy device wins FDA authorization – Medtechdive.com
“Now, ATT wants to render the foam versus gauze debate irrelevant for many wounds by introducing a device that has built-in filler material. ATT’s Platform
Xpansion Featured in Clinic Evaluation
Xpansion featured in a clinic evaluation presented by Lisa Gould MD, PhD, FACS on Woundsresearch.com Click here to watch the video
Xpansion MicroAutografting kit is now available in Israel exclusively through Tzur Medical
Applied Tissue Technologies has reached an agreement that will provide Tzur Medical with exclusive distribution of the Xpansion MicroAutografting kit in Israel. We are excited
Platform Wound Device wins Oral presentation at the Wound Healing Society Meeting in San Diego, April 2017. Topical Delivery of an antibiotic enclosed in the PWD on a full thickness burn demonstrates penetration of the eschar in a porcine model.
The drug delivery enabling technology of the PWD will be demonstrated at the American Burn Association meeting on March 21-24, 2017 in Boston, MA. Dr.
Platform Wound Device/ New Breakthrough in NPWT to be presented at SAWC Poster Session April 2017. Embossed device eliminates the need for foam or gauze wound filler when treating wounds with Negative Pressure Wound Therapy
Dr. Elof Eriksson M.D. Ph.D. will present a poster entitled, “A New Negative Pressure Wound Therapy Device without Foam or Gauze” on Friday, April 7,
Xpansion MicroAutografting kit is now available in Australia and New Zealand through Ozmedix
Applied Tissue Technologies has reached an agreement that will provide Ozmedix with exclusive distribution of the Xpansion MicroAutografting kit in Australia and New Zealand. Xpansion®
Xpansion MicroAutografting to be presented at SAWC Poster Session in San Diego, April 2017
Dr. Debora Sanches Pinto of Sao Paulo University Hospital, Sao Paulo, Brazil will present a poster entitled, “Outpatient Minced split-thickness skin grafts for burn wounds
Xpansion MicroAutografting Kit provides Outpatient Split-thickness Skin Grafting utilizing Local Anesthetic. Demonstrated at the SAWC in Las Vegas, Nevada, September 26 thru September 28, 2015, Booth #515
Visit the SteadMed Medical LLC booth #515 at the 2015 fall SAWC in Las Vegas, Nevada for a demonstration of the Xpansion Micro-Autografting Kit. Xpansion
SBIR Phase II Grant Awarded for Next Generation NPWT and Delivery Platform
April 4, 2015 Newton, Massachusetts Applied Tissue Technologies has been awarded a Phase II SBIR grant to further investigate it’s next generation NPWT
Japan Issues New Patent for Next Generation Negative Pressure Wound Therapy Device
October 10, 2014 Newton, MA Applied Tissue Technologies was issued yet another patent for their new next generation negative pressure device. The device eliminates the
Another New Patent for Applied Tissue Technologies NPWT technology. Innovative technology and simplified design eliminates the foam or gauze wound filler.
April 17, 2014 Newton, Massachusetts Applied Tissue Technologies LLC announces news in advanced wound care with: An additional patent for simplifying the use of negative
Applied Tissue Technologies Announces additional Patent for next generation negative pressure wound therapy device
April 10, 2014 Newton, Massachusetts Applied Tissue Technologies LLC announces news in advanced wound care with: An additional patent for simplifying the use of negative
Applied Tissue Technologies Breakthrough NPWT design wins SBIR grant
February 4, 2014 Newton, Massachusetts Following on the heels of the issuance of USPTO patent number 8,632,523, describing a revolutionary method and
Applied Tissue Technologies announces the issuance of a new patent simplifying the use of negative pressure wound therapy with a breakthrough design
January 30, 2014 Newton, Massachusetts Applied Tissue Technologies LLC announces news in advanced wound care with: The issuance of a new patent
Xpansion is now exclusively distributed in the western hemisphere by
Applied Tissue Technologies and SteadMed® Medical have partnered to bring distribution of Xpansion to the Western Hemisphere. www.steadmed.com
ISO 13485:2003 Certified
Applied Tissue Technologies LLC has obtained ISO 13485 certification using BSI as its notified body. We have also secured CMDCAS certification in Canada for the
Clinical Trials to begin at Southern Illinois University and McGill University
Applied Tissue Technologies has enrolled the Xpansion Skin Grafting Instrument kit in two clinical trials. The trials will start in the 2nd quarter of 2013,
Skin Grafting news at SAWC
Sterile Single Use Xpansion Micrografting System for harvesting and transplanting STSG autografts News at Spring SAWC 2013 Management of Skin Grafts Using Negative Pressure Therapy: The
Severe Burn, Wound Treatment… Applied Tissue Technologies’ XPANSION® utilized in Iraqi warzone
This article details the use of Xpansion and micrografting on an Iraqi civilian who sufferred burns in the Iraq war on more than 50% of
Micrografting Study published in the Journal of Plastic and Reconstructive Surgery
BOSTON, MA – April 2, 2012 – Applied Tissue Technologies, LLC a leading manufacturer of wound healing technologies, today announced the latest publication describing the